Active Ingredient
SALICYLIC ACID.......... 1.5% W/W
Personox Ultimate Scrub Cleanser Cream
FDA Label NDC 83044-101
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Stonebridge Consultants Llc for the product Personox Ultimate Scrub Cleanser (NDC 83044-101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, otc - keep out of reach of children, directions, inactive ingredients, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
ACNE TREATMENT
Uses
FOR THE TREATMENT OF ACNE
Warnings
FOR EXTERNAL USE ONLY
WHEN USING THIS PRODUCT
- AVOID CONTACT WITH EYES AND MOUTH. IF CONTACT OCCURS, RINSE THOROUGHLY WITH WATER.
- SKIN IRRITATION AND DRYNESS IS MORE LIKELY TO OCCUR IF YOU USE ANOTHER TOPICAL ACNE MEDICATION AT THE SAME TIME. IF IRRITATION OCCURS, ONLY USE ONE TOPICAL MEDICATION AT A TIME.
- LIMIT USE TO FACE AND NECK.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
IF PRODUCT IS SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
Directions
CLEANSE UP TO TWICE A DAY OR AS INSTRUCTED BY A PHYSICIAN. WET FACE, APPLY A SMALL AMOUNT OF PRODUCT TO WET HANDS AND WORK INTO A LATHER ON AREAS TO BE TREATED - MASSAGE GENTLY, RINSE THOROUGHLY.
Inactive Ingredients
WATER, SILICA DIOXIDE, COCO-GLUCOSIDE, SODIUM ISETHIONATE, POLOXAMER 184, SODIUM DIOCTYL SULFOSUCCINATE, SODIUM DODECYLBENZENESULFONATE, SULFUR, CORN STARCH, CELLULOSE GUM, FRAGRANCE, TETRASODIUM EDTA, MAGNESIUM ALUMINUM SILICATE
Other Information
- STORE IN A COOL DRY PLACE
- DO NOT FREEZE
Package Label.Principal Display Panel
* Please review the disclaimer below.
